176 related articles for article (PubMed ID: 38555324)
1. 5-Methylcytosine immunohistochemistry for predicting cutaneous melanoma prognosis.
Meevassana J; Varophas S; Prabsattru P; Kamolratanakul S; Ruangritchankul K; Kitkumthorn N
Sci Rep; 2024 Mar; 14(1):7554. PubMed ID: 38555324
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of genome-wide 5-methylcytosine level is an epigenetic feature of cutaneous malignant melanomas.
Micevic G; Theodosakis N; Taube JM; Bosenberg MW; Rodić N
Melanoma Res; 2017 Apr; 27(2):85-96. PubMed ID: 27997431
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
Yang B; Sun H; Lin W; Hou W; Li H; Zhang L; Li F; Gu Y; Song Y; Li Q; Zhang F
Urol Oncol; 2013 Jul; 31(5):628-34. PubMed ID: 21704537
[TBL] [Abstract][Full Text] [Related]
4. Utility of 5-Methylcytosine Immunohistochemical Staining to Assess Global DNA Methylation and Its Prognostic Impact in MDS Patients.
Chandra D; Tyagi S; Singh J; Deka R; Manivannan P; Mishra P; Pati HP; Saxena R
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3307-3313. PubMed ID: 29286224
[TBL] [Abstract][Full Text] [Related]
5. Global methylation of blood leukocyte DNA and risk of melanoma.
Shen J; Song R; Wan J; Huff C; Fang S; Lee JE; Zhao H
Int J Cancer; 2017 Apr; 140(7):1503-1509. PubMed ID: 28006848
[TBL] [Abstract][Full Text] [Related]
6. High-frequency p16(INK) (4A) promoter methylation is associated with histone methyltransferase SETDB1 expression in sporadic cutaneous melanoma.
Kostaki M; Manona AD; Stavraka I; Korkolopoulou P; Levidou G; Trigka EA; Christofidou E; Champsas G; Stratigos AJ; Katsambas A; Papadopoulos O; Piperi C; Papavassiliou AG
Exp Dermatol; 2014 May; 23(5):332-8. PubMed ID: 24673285
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Pavlova O; Fraitag S; Hohl D
J Invest Dermatol; 2016 Dec; 136(12):2453-2461. PubMed ID: 27456754
[TBL] [Abstract][Full Text] [Related]
9. Distinct global DNA methylation status in B-cell lymphomas: immunohistochemical study of 5-methylcytosine and 5-hydroxymethylcytosine.
Matsuda I; Imai Y; Hirota S
J Clin Exp Hematop; 2014; 54(1):67-73. PubMed ID: 24942948
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer.
Zhang LY; Li PL; Wang TZ; Zhang XC
Arch Gynecol Obstet; 2015 Oct; 292(4):891-7. PubMed ID: 25827305
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic modifications in cutaneous malignant melanoma: EZH2, H3K4me2, and H3K27me3 immunohistochemical expression is enhanced at the invasion front of the tumor.
Kampilafkos P; Melachrinou M; Kefalopoulou Z; Lakoumentas J; Sotiropoulou-Bonikou G
Am J Dermatopathol; 2015 Feb; 37(2):138-44. PubMed ID: 25614949
[TBL] [Abstract][Full Text] [Related]
12. 5-methylcytosine and its derivatives.
Yuan BF
Adv Clin Chem; 2014; 67():151-87. PubMed ID: 25735861
[TBL] [Abstract][Full Text] [Related]
13. TSLC1 gene silencing in cutaneous melanoma.
You Y; Ma L; You M; Li X; Wang S; Li H; Wu D; Yang H; Li ZY
Melanoma Res; 2010 Jun; 20(3):179-83. PubMed ID: 20375924
[TBL] [Abstract][Full Text] [Related]
14. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
[TBL] [Abstract][Full Text] [Related]
15. The dynamics of DNA methylation and hydroxymethylation during amelogenesis.
Yoshioka H; Minamizaki T; Yoshiko Y
Histochem Cell Biol; 2015 Nov; 144(5):471-8. PubMed ID: 26209269
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of tumor suppressor genes in serum of patients with cutaneous melanoma.
Marini A; Mirmohammadsadegh A; Nambiar S; Gustrau A; Ruzicka T; Hengge UR
J Invest Dermatol; 2006 Feb; 126(2):422-31. PubMed ID: 16374457
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Saldanha G; Joshi K; Lawes K; Bamford M; Moosa F; Teo KW; Pringle JH
Mod Pathol; 2017 Jan; 30(1):60-68. PubMed ID: 27713424
[TBL] [Abstract][Full Text] [Related]
18. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.
Yamamoto Y; Matsusaka K; Fukuyo M; Rahmutulla B; Matsue H; Kaneda A
Cancer Med; 2020 Oct; 9(19):7194-7204. PubMed ID: 32406600
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin 1 protein expression is associated with BRAF V600 mutation and adverse prognosis in cutaneous melanoma.
Imrédi E; Tóth B; Doma V; Barbai T; Rásó E; Kenessey I; Tímár J
Melanoma Res; 2016 Jun; 26(3):254-60. PubMed ID: 26848795
[TBL] [Abstract][Full Text] [Related]
20. Whole-genome DNA methylation and hydroxymethylation profiling for HBV-related hepatocellular carcinoma.
Ye C; Tao R; Cao Q; Zhu D; Wang Y; Wang J; Lu J; Chen E; Li L
Int J Oncol; 2016 Aug; 49(2):589-602. PubMed ID: 27221337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]